Expediting the development of robust 5-FU-resistant colorectal cancer models using innovative combined in vivo and in vitro strategies
Our integrated approach rapidly develops colorectal cancer cells with robust 5-FU resistance, offering a potent model for exploring multiple resistance pathways and counter-resistance strategies.
Authors
- Zunyun Wang
- Xiling Xu (ORCID: https://orcid.org/0009-0008-8346-0155)
- Ming Shao (ORCID: https://orcid.org/0000-0002-9476-5308)
- Juan Du (ORCID: https://orcid.org/0000-0001-8144-7792)
- Jiyuan Shi
- Yunran Gao
Institutions
- Anhui Medical University (CN)
- Chinese University of Hong Kong, Shenzhen (CN)
- Shenzhen University Health Science Center (CN)
Publication Details
- Journal
- Biomedicine & Pharmacotherapy
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1016/j.biopha.2024.117576
- Citations
- 2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Natural Science Foundation of China